Rafi Gidron

Angel Investor Israel
LinkedIn
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

Rafi Gidron is a serial entrepreneur and angel investor, co-founder and board member in many startups including Chromatis, E-toro, Zoomd, BiomX, BitDam, Scorpio, ArtAi, Worthy, nanofabrica, Semperis, Vibrant, Voyage 81, Xperiti, and many others. He is most known for founding and managing Chroamtis - an Israeli Unicorn. He has also co-founded two non-profit national initiatives under the auspices of the late President Shimon Peres: Israel Brain Technologies and a nanotechnology initiative. Dr. Gidron holds a Ph.D. degree in EE from Columbia University, New York, NY, and was associate director of the Center for Telecommunication Research of the National Science Foundation. He is currently involved with a few startup companies including ArtAi, Prickly Bear, Voyage81, Xperiti, and is actively investing in new early-stage companies.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Rafi Gidron's primary role in the Israeli startup ecosystem?
Rafi Gidron is a serial entrepreneur and angel investor in Israel. He is also a co-founder and board member in many startups.
Which notable company did Rafi Gidron found and manage?
Rafi Gidron is most known for founding and managing Chromatis, an Israeli Unicorn.
What are some of Rafi Gidron's recent investment activities?
Rafi Gidron actively invests in new early-stage companies. His recent investments include Vyzer in October 2023 ($6.3M) and dig in July 2022 ($8M).
What is Rafi Gidron's investment range for early-stage companies?
Rafi Gidron's investment range is between $500K and $8M, focusing on A Round, Pre-Seed, and Seed stages.
Which sectors does Rafi Gidron primarily invest in?
According to startupim data, Rafi Gidron's portfolio shows a concentration in Health Tech & Life Sciences and Business Software, with 3 companies in each sector.
Has Rafi Gidron had any notable exits from his portfolio companies?
Yes, Rafi Gidron has had several exits. BioProtect was acquired by Almeda Ventures in January 2026 for $200M, and Crosswise was acquired by Oracle in April 2016 for $50M.
What is Rafi Gidron's educational background?
Rafi Gidron holds a B.S. in Engineering from Tel Aviv University (1985) and a Ph.D. in EE from Columbia University (1991).
Is Rafi Gidron currently involved with any specific startup companies?
Yes, Rafi Gidron is currently involved with ArtAi, Prickly Bear, Voyage81, and Xperiti.